Xiya Lu

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Early Response to Vunakizumab at Week 2 Predicts Favourable Long-Term Efficacy in Patients With Moderate-To-Severe Plaque Psoriasis: A Post Hoc Analysis of a Phase III, Randomised Controlled Trial.

Early Response to Vunakizumab at Week 2 Predicts Favourable Long-Term Efficacy in Patients With Moderate-To-Severe Plaque Psoriasis: A Post Hoc Analysis of a Phase III, Randomised Controlled Trial.

Journal: Immunology

Published: September 11, 2025

BMP9 functions as a negative regulator in the myogenic differentiation of primary mouse myoblasts.

BMP9 functions as a negative regulator in the myogenic differentiation of primary mouse myoblasts.

Journal: Bioscience, biotechnology, and biochemistry

Published: March 31, 2023

Bullous Pemphigoid Associated with Erythrodermic Psoriasis: A Case Report.

Bullous Pemphigoid Associated with Erythrodermic Psoriasis: A Case Report.

Journal: Clinical, cosmetic and investigational dermatology

Published: May 25, 2022

Risk Factors of Atrial Arrhythmia in Patients With Liver Cirrhosis: A Retrospective Study.

Risk Factors of Atrial Arrhythmia in Patients With Liver Cirrhosis: A Retrospective Study.

Journal: Frontiers in cardiovascular medicine

Published: May 01, 2021

Gut microbes in gastrointestinal cancers.

Gut microbes in gastrointestinal cancers.

Journal: Seminars in cancer biology

Published: January 14, 2021

Exercise and Type 1 Diabetes.

Exercise and Type 1 Diabetes.

Journal: Advances in experimental medicine and biology

Published: April 29, 2020

Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-β1/Smad3 and TGF-β1/p38 MAPK Pathways.

Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-β1/Smad3 and TGF-β1/p38 MAPK Pathways.

Journal: Mediators of inflammation

Published: March 06, 2019

Vitiligo in a patient receiving infliximab for chronic plaque psoriasis.

Vitiligo in a patient receiving infliximab for chronic plaque psoriasis.

Journal: Dermatologic therapy

Published: February 21, 2019

Beraprost sodium preconditioning prevents inflammation, apoptosis, and autophagy during hepatic ischemia-reperfusion injury in mice via the P38 and JNK pathways.

Beraprost sodium preconditioning prevents inflammation, apoptosis, and autophagy during hepatic ischemia-reperfusion injury in mice via the P38 and JNK pathways.

Journal: Drug design, development and therapy

Published: December 21, 2018

Salidroside ameliorates autophagy and activation of hepatic stellate cells in mice via NF-κB and TGF-β1/Smad3 pathways.

Salidroside ameliorates autophagy and activation of hepatic stellate cells in mice via NF-κB and TGF-β1/Smad3 pathways.

Journal: Drug design, development and therapy

Published: July 05, 2018

Alleviation of hepatic fibrosis and autophagy via inhibition of transforming growth factor-β1/Smads pathway through shikonin.

Alleviation of hepatic fibrosis and autophagy via inhibition of transforming growth factor-β1/Smads pathway through shikonin.

Journal: Journal of gastroenterology and hepatology

Published: January 23, 2018

Isorhamnetin: A hepatoprotective flavonoid inhibits apoptosis and autophagy via P38/PPAR-α pathway in mice.

Isorhamnetin: A hepatoprotective flavonoid inhibits apoptosis and autophagy via P38/PPAR-α pathway in mice.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 18, 2017

Showing 1-12 of 25

Last Updated: 09/26/2026